[1] | Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 2000; 54: S4-S9. |
[2] | Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007; 29: 125-132. |
[3] | Kalaria RN., Maestre GE., Arizaga R., et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 2008; 7: 812-826. |
[4] | Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112-2117. |
[5] | Wimo A, Winblad B, Agüero-Torres H, et al. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 2003; 17: 63-67. |
[6] | Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007; 3: 186-191. |
[7] | Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000; 54: S10-S15. |
[8] | Kawas C, Gray S, Brookmeyer R, Fozard J, et al. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 2000; 54: 2072-2077. |
[9] | Kukull WA, Higdon R, Bowen JD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 2002; 59: 1737-1746. |
[10] | Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006; 368: 387-403. |
[11] | Helzner EP, Scarmeas N, Cosentino S, et al. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology 2008; 71: 1489-1495. |
[12] | Mehta KM, Yaffe K, Pérez-Stable EJ, et al. Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology 2008; 70: 1163-1170. |
[13] | Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006; 368: 387–403. |
[14] | Aggarwal NT, Bienias JL, Bennett DA, et al. The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population. Neuroepidemiology 2006; 26: 140–146. |
[15] | Anstey KJ, von Sanden C, Salim A, et al. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007; 166:367–378. |
[16] | Ding J, Eigenbrodt ML, Mosley T H Jr, et al. Alcohol intake and cerebral abnormalities on magnetic resonance imaging in a community-based population of middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2004; 35: 16–21. |
[17] | Paul CA, Au R, Fredman L, et al. Association of alcohol consumption with brain volume in the Framingham study. Arch Neurol 2008; 65: 1363–1367. |
[18] | Rosengren A, Skoog I, Gustafson D, et al. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med 2005; 165: 321–326. |
[19] | Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009; 66: 336–342. |
[20] | Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E Â4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002; 137: 149–155. |
[21] | Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000; 21: 49–55. |
[22] | Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001; 322: 1447–1451. |
[23] | Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004; 61: 661–666. |
[24] | Irie F, Fitzpatrick AL, Lopez OL, et al. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE e4: the Cardiovascular Health Study Cognition Study. .Arch Neurol. 2008; 65: 89–93. |
[25] | Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215–1222. |
[26] | Honig LS, Tang MX, Albert S, et al. Stroke and the risk of Alzheimer disease. Arch Neurol 2003; 60: 1707–1712. |
[27] | Blum S, Luchsinger JA, Manly JJ, et al. Memory after silent stroke: hippocampus and infarcts both matter. Neurology 2012 Jan 3; 78 (1): 38-46. |
[28] | WU YC, Lin YC, YU HL, et al. Association between air pollutants and dementia risk in the elderly. Alzheimers Dement (Amst) 2015 May 14; 1 (2): 220-8. |
[29] | Calderón-Garcidueñas L, Calderón-Garcidueñas A, Torres-Jardón R, et al. Air pollution and your brain: what do you need to know right now. Prim Health Care Res Dev 2015 Jul; 16 (4): 329-45. |
[30] | Weuve J. Invited commentary: how exposure to air pollution may shape dementia risk, and what epidemiology can say about it. Am J Epidemiol 2014 Aug 15; 180 (4): 367-71. |
[31] | Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009; 11 (2): 111-28. Review. |
[32] | Miklossy J. Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med 2011 Sep 20; 13: e30. doi: 10.1017/S1462399411002006. |
[33] | Malaguarnera M, Bella R, Alagona G, et al. Helicobacter pylori and Alzheimer's disease: a possible link. Eur J Int Med 2004 Oct; 15 (6): 381-386. |
[34] | Roubaud Baudron C, Varon C, Mégraud F, et al. Alzheimer's disease and Helicobacter pylori infection: a possible link? . Geriatr Psychol Neuropsychiatr Vieil 2016 Mar; 14 (1): 86-94. |
[35] | Roubaud Baudron C, Krolak-Salmon P, Quadrio I, et al. Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results. Neurobiol Aging 2012 May; 33 (5): 1009. e11-9. doi: 10.1016/j.neurobiolaging.2011.10.021. Epub 2011 Dec 1. |
[36] | Roubaud Baudron C, Varon C, Mégraud F, et al. Alzheimer's disease: the infectious hypothesis. Geriatr Psychol Neuropsychiatr Vieil 2015 Dec; 13 (4): 418-24. |
[37] | Adriani A, Fagoonee S, De Angelis C, et al. Helicobacter pylori infection and dementia: can actual data reinforce the hypothesis of a causal association? Panminerva Med 2014 Sep; 56 (3): 195-9. |
[38] | Roubaud Baudron C, Letenneur L, Langlais A, et al. Does Helicobacter pylori infection increase incidence of dementia? The Personnes Agées QUID Study. J Am Geriatr Soc 2013 Jan; 61 (1): 74-8. |
[39] | Alvarez-Arellano L, Maldonado-Bernal C. Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J Gastrointest Pathophysiol 2014 Nov 15; 5 (4): 400-4. |
[40] | Farinha P, Gascoyne RD. Helicobacter pylori and MALT Lymphoma. Gastroenterology 2005 May; 128 (6): 1579-605. |
[41] | Nasrat AM, Nasrat SAM, Nasrat RM, et al. Misconception and misbehavior towards Helicobacter pylori is leading to major spread of illness. GM 2015; S1 (002). [Open Access] |
[42] | Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002 Dec; 17 (4): 221-7. |
[43] | Albert MS. Cognitive and neurobiologic markers of early Alzheimer disease. Proc Natl Acad Sci U S A 1996 Nov 26; 93 (24): 13547-51. |
[44] | Aguilar MA, Minarro J, Felipo V. Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp Neurol 2000; 161: 704-713. |
[45] | Shukla M, Boontem P, Reiter RJ, et al. Mechanisms of melatonin in alleviating Alzheimer's disease. Curr Neuropharmacol 2017 Mar 13. doi: 10.2174/1570159X15666170313123454. [Epub ahead of print] |
[46] | Andreeva TV, Lukiw WJ, Rogaev EI. Biological Basis for Amyloidogenesis in Alzheimer's Disease. Biochemistry (Mosc) 2017 Feb; 82 (2): 122-139. |
[47] | Cahill MK, Huang EJ. Testing the Amyloid Hypothesis with a Humanized AD Mouse Model. Neuron 2017 Mar 8; 93 (5): 987-989. |
[48] | Kosenko EA, Solomadin IN, Tikhonova LA, et al. Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemicammonia and erythrocyte energy metabolism. CNS Neurol Disord Drug Targets 2014 Feb; 13 (1): 112-9. |
[49] | Seiler N. Ammonia and Alzheimer's disease. Neurochem Int 2002 Aug-Sep; 41 (2-3): 189-207. |
[50] | Seiler N. Is ammonia a pathogenetic factor in Alzheimer's disease? Neurochem Res 1993 Mar; 18 (3): 235-45. |
[51] | Wright PA. Nitrogen excretion: three end products, many physiological roles. J Exp Biol 1995; 198 (2): 273-281. |
[52] | Marcaida G, Felipo V, Hermenegildo C, et al. Acute ammonia toxicity is mediated by the NMDA type of glutamate receptors. FEBS Lett 1992 Jan 13; 296 (1): 67-8. |
[53] | Britto DT, Kronzucker HJ. NH4+ toxicity in higher plants: a critical review. J Plant Physiol 2002; 159 (6): 567-584. |
[54] | Adlimoghaddam A, Sabbir MG, Albensi BC. Ammonia as a Potential Neurotoxic Factor in Alzheimer's Disease. Front Mol Neurosci 2016 Aug 8; 9: 57. doi: 10.3389/fnmol.2016.00057. |
[55] | Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987; 67: 440-519. |
[56] | Seglen PO. Inhibitors of lysosomal function. Meth Enzymol 1983; 96: 737-764. |
[57] | Marcaggi P, Coles JA. Ammonium in nervous tissue: transport across cell membranes, fluxes from neurons to glial cells, and role in signalling. Prog Neurobiol 2001; 64: 157-183. |
[58] | Laursen H, Diemer NH. Morphometric studies of rat glial cell ultrastructure after urease-induced hyperammonaemia. Neuropathol Appl Neurobiol 1979; 5: 345-362. |
[59] | Fiorentino M, Sapone A, Senger S, et al. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Mol Autism 2016 Nov 29; 7: 49. eCollection 2016. |
[60] | Hrnjez BJ, Song JC, Prasad M, et al. Ammonia blockade of intestinal epithelial K+ conductance. Am J Physiol 1999; 277 (3): 521-532. |
[61] | Sumii T, Nakano Y, Abe T, et al. The Effect of Nitric Oxide on Ammonia Decomposition in Co-cultures of Hepatocytes and Hepatic Stellate Cells. In Vitro Cell Dev Biol Anim 2016 Jun; 52 (6): 625-31. |
[62] | Nasrat AM, El-Sayed SM, Shabaka AA, et al. Male pelvic congestion and erectile dysfunction; obscure reasons for an obvious phenomenon among the young. GM 2016; S1 (1). [Open Access] |
[63] | Malinski T. Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis 2007 May; 11 (2): 207-18. |
[64] | Hartlage-Rübsamen M, Apelt J, Schliebs R. Fibrillary beta-amyloid deposits are closely associated with atrophic nitric oxide synthase (NOS)-expressing neurons but do not upregulate the inducible NOS in transgenic Tg2576 mouse brain with Alzheimer pathology. Neurosci Lett 2001 Apr 20; 302 (2-3): 73-6. |
[65] | Hu ZI, Kotarba AM, Van Nostrand WE. Absence of Nitric Oxide Synthase 3 Increases Amyloid βProtein Pathology in Tg-5xFAD Mice. Neurosci Med 2013 Jun; 4 (2): 84-91. |
[66] | Nasrat AM. The world misconception and misbehavior towards Helicobacter pylori is leading to major spread of illness. The 7th Anti-Aging Medicine World Congress, Monte-Carlo, Monaco, 2009 Mar. Available from URL, www.euromedicom.com |
[67] | Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987; 67: 440-519. |
[68] | Chang YP, Chiu GF, Kuo FC, et al. Eradication of Helicobacter pylori is associated with the progression of dementia: A population-based study. Gastroenterol Res Pract 2013; 2013: 175729. doi: org/10.1155/2013/175729. Epub 2013 Nov 25. |
[69] | Adlimoghaddam A, Sabbir MG, Albensi BC. Ammonia as a potential neurotoxic factor in Alzheimer's disease. Front Mol Neurosci 2016 Aug 8; 9: 57. doi: 10.3389/fnmol.2016.00057. eCollection 2016. |
[70] | Nasrat SAM, Nasrat RM, Nasrat MN, et al. The dramatic spread of diabetes mellitus worldwide and influence of Helicobacter pylori. General Med. 2015; 3 (1): 159-62. |
[71] | Nasrat SAM, Nasrat AM. An alternative approach for the rising challenge of hypertensive illness via Helicobacter pylori eradication. Cardiol Res. 2015. [Open Access] doi: org/10.14740/cr382e. |
[72] | Aksoy H, Sebin SO. H. pylori and cardiovascular diseases. General Med. 2015; S1: 1. [Open Access] doi: org/10.4172/2327-5146.1000S1-007. |